Keywords: 5-HT1A; serotonin 1A receptor; AE; adverse events; AIDS; acquired immunodeficiency syndrome; CB1; cannabinoid-one receptor; CB2; cannabinoid-two receptor; CBD; cannabidiol; CBDA; cannabidiolic acid; CRISP-R; Clustered Regularly Interspaced Short Palindrom
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 2-AG; 2-arachidonoylglycerol; ANOVA; analysis of variance; BLA; basolateral nucleus of amygdala; BSA; bovine serum albumin; CA1; dorsal field 1 of Ammon's horn; CA3; dorsal field 3 of Ammon's horn; CB1; cannabinoid receptor 1; CeA; central amygdaloid
Keywords: ACQ; acquisition; ANOVA; analysis of variance; CB1; cannabinoid receptor 1; GABA; γ-aminobutyric acid; GEE; generalized estimating equations; HPA; hypothalamus-pituitary-adrenal axis; i.p.; intraperitoneal application; LPS; lipopolysaccharide; MaxT; maxi
Keywords: Renal fibrosis; TGFβ; Pirfenidone; Endothelin-receptor A blockers; Galectin-3; Periostin; DDR1; CB1; miRNA; CKD; Biomarker; Collagen degradation products; Urinary exosomes; Targeted therapy;
Keywords: CES; cortical electrical stimulation; ESI; electrical stimulation of the insular cortex; MOR; mu opioid receptor; CB1; type 1 cannabinoid receptor; NeP; neuropathic pain; TMS; transcranial magnetic stimulation; CCI; chronic constriction injury; S.E.M.; st
Keywords: Cannabinoids; Phytocannabinoids; Endocannabinoids; Therapeutic agents; AEA; Arachidonylethanolamine or Anandamide; 2-AG; 2-arachidonylglycerol; CB1; Cannabinoid receptor type 1; CB2; Cannabinoid receptor type 2; CBD; Cannabidiol; CBG; Cannabigerol; CBL; C
Keywords: AEA; anandamide; BS; behavioral sensitization; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CL; conditioned locomotion; Coc; cocaine; CPP; conditioned place preference; CS+; positive conditioned stimulus; CS-; neutral conditioned st
Keywords: Opioids; Analgesia; Adverse effects; Mechanisms; Constipation; Nausea; Vomiting; Respiratory depression; 5-HT; 5-hydroxytryptamine; 7TMRs; 7-transmembrane spanning G-protein coupled receptors; AC; adenylyl cyclase; β-arr1; β-arrestin1; β-arr2; β-arres
Keywords: AUD; Alcohol use disorder; FDA; Food and Drug Administration; MOR; Mu opioid receptor; DOR; Delta opioid receptor; KOR; Kappa opioid receptor; NMDA; N-methyl-d-aspartate; GABA; Gaba amino butyric acid; DSM-IV; Diagnostic and statistical measurement IV; PA
Keywords: Fattening; Adiposity; Endocannabinoid; CB1; Oleoylethanolamide; Palmitoylethanolamide;
Keywords: cannabinoid receptors; CB1; endocannabinoids; fatty acid amide hydrolase; FAAH; polycystic ovary syndrome; PCOS; metformin;
Keywords: 2-AG; arachidonoylglycerol; AI; alkylindole; CB; cannabinoid; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; CSA4; combretastatin A4; DBT; delayed Brain Tumor; HA; hemagglutinin; LPA; lysophosphatidic acid; GBM; glioblastoma multiforme; SAR; st
Keywords: Antinociception; CB2 cannabinoid receptor agonist; Inflammation; Morphine; Reward; Synergy; 2-AG; 2-arachidonoylglycerol; %MPE; percent maximal possible effect; A50; potency; a-CSF; artificial spinal fluid; CB1; cannabinoid 1 receptor; CB2; cannabinoid 2
Keywords: CB1; Antipsychotic; High fat diet;
Keywords: Avoidance behavior; Response extinction; CB1 receptors; Dopamine D1 receptors; AM404; SDA; step-down inhibitory avoidance; C57BL/6N; C57BL/6NCrl; EBT; exposure based therapy; ECS; endocannabinoid system; D1-CB1â/â; conditional D1-CB1 knock-out mic
Keywords: 2-AG; 2-arachidonoyglycerol; AEA; arachidonoylethanolamide; AEs; acylethanolamides; CB1; cannabinoid receptor 1; CB2; cannabinoid receptor 2; DAGL; diacylglycerol lipase; eCBs; endocannabinoids; ECS; endogenous cannabinoid system; FAAH; fatty acid amide h
Keywords: 5-HIAA; 5-hydroxyindole-3-acetic acid; AMPA; aminohydroxymethyl isoxazole propionate receptor; ANOVA; analysis of variance; BLA; basolateral nucleus of the amygdala; CA; Ammon's horn of the hippocampus; CB1; cannabinoid subtype 1 receptor; CB2; cannabin
Keywords: Homeostasis; Obesity; Pharmacotherapy; Reward; AgRP; agouti-related protein; α-MSH; alpha-melanocyte stimulating hormone; 2-AG; 2-arachidonoylglycerol; BDNF; brain derived neurotrophic factor; BOLD; blood-oxygen level dependent; CB1; cannabinoid-1; CB2;
Keywords: ADF; acid detergent fibre expressed inclusive residual ash; ADIN; acid detergent insoluble nitrogen; CA; rapidly degradable sugars; CB1; intermediately degradable starch and pectins; CB2; slowly degradable plant cell wall; CC; unavailable/lignin-bound cel
Keywords: 2-AG; 2-arachidonoylglycerol; ALK; anaplastic lymphoma kinase; ATF-4; activating transcription factor 4; CB1; cannabinoid CB1 receptor; CB2; cannabinoid CB2 receptor; CBD; cannabidiol; CHOP; C/EBP homologous protein; EGFR; epidermal growth factor receptor
Keywords: Scopolamine; Basolateral amygdala; Endocannabinoid system; Passive avoidance task; Rat(s); CB1; cannabinoid receptor; i.p.; intraperitoneal; BLA; basolateral amygdala; ACPA; arachydonilcyclopropylamide; ACh; acetylcholine; AD; alzheimer disease; LTP; long
Keywords: L; Dopa (levedopa); MAO; inhibitors (monoamine oxidase B); COMPT; inhibitors (catechol-o-methyl transferase); MPTP; (1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine); MPPP; (1-Methyl-4-phenyl-4-propionoxypiperidine); MPDP; (1-Methyl-4-phenyl-1, 2-dihydrox
Keywords: 2-AG; 2-arachidonoylglycerol; AA; arachidonic acid; ABHD4; α/β-hydrolase domain-containing protein 4; ABHD6; α/β-hydrolase domain-containing protein 6; ABHD12; α/β-hydrolase domain-containing protein 12; AEA; arachidonoylethanolamine; CB1; cannabino
Keywords: (2-AG); 2-arachidonoyl-glycerol; (â9-THC); delta-9-tetrahydrocannabinol; (AA); Alko Alcohol preferring; (ABHD); alpha/beta hydrolase domain-containing protein; (ADE); alcohol deprivation effect; (AEA); N-arachidonoylethanolamine; (CB1); cannabinoid rece
Keywords: 2-AG; 2-arachidonoyl-glycerol; AEA; anandamide; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; central nervous system; DOPAC; 3,4-Dihydroxyphenylacetic acid; DA; dopamine; D2; dopamine receptor subtype 2; ECS; endocannabinoid sys
Keywords: AEA; N-arachidonoylethanolamine; 2-AG; 2-arachidonoylglycerol; ALT; alanine aminotransferase; ARA; arachidonic acid; CB1; cannabinoid receptor 1; DHA; docosahexaenoic acid; EPA; eicosapentaenoic acid; LA; linoleic acid; LDH; lactate dehydrogenase; NAFLD;
Keywords: WKY; Wistar Kyoto; SD; Sprague-Dawley; qRT-PCR; quantitative real time polymerase chain reaction; AEA; anandamide; 2-AG; 2-arachidonoylglycerol; MAGL; monoacylglycerol lipase; FAAH; fatty acid amide hydrolase; CB1; cannabinoid receptor 1; SIH; stress-in
Keywords: BDL; bile duct ligation; CB1; Cannabinoid receptor-1; GdCl3; gadolinium chloride; AEA; anandamide; 2-AG; 2-arachidonoyl glycerol; ESPVR; end-systolic pressure-volume relationship; Cirrhosis; Cardiomyopathy; Endocannabinoids; AM251; Hemorrhage; CB-1; Monoc
Keywords: AEF; atrioesophageal fistula; AF; atrial fibrillation; AT; atrial tachycardia; CB; cryoballoon; CB1; first-generation cryoballoon; CB2; second-generation cryoballoon; CI; confidence interval; EFI; early freezing interruption; LET; luminal esophageal tempe
Keywords: AEME; anhydroecgonine methyl ester; CB1; cannabinoid type 1 receptor; DAT; dopamine transporter; VTA; ventral tegmental area; NAc; nucleus accumbens; PFC; prefrontal cortex (PFC); eCB; endocannabinoid; GC-MS; gas chromatography-mass spectrometry; BE;
Keywords: Akt; protein kinase B; CB1; cannabinoid type-1 receptor; CB2; cannabinoid type-2 receptor; D2; dopamine type-2 receptor; Î9-THC; Î9-tetrahydrocannabinol; EEG; electroencephalography; ERK; extracellular signal-regulated kinase; FAAH; fatty acid amide hyd
Keywords: AEA; anandamide; ANOVA; analysis of variance; ARRIVE; Animal Research: Reporting of In Vivo Experiments guidelines; BDNF; brain-derived neurotrophic factor; BK; Big Potassium channels; CBr; cannabinoid receptors; CBs; cannabinoids; CB1; type-1 cannabinoid
Keywords: 2-AG; 2-arachidonoylglycerol; CB1; cannabinoid receptor 1; CORT; corticosterone; COX-2; cyclooxygenase-2; CRD; colorectal distension; DRG; dorsal root ganglion; EMG; electromyography; GR; glucocorticoid receptor; FAAH; fatty acid amide hydrolase; HPA; hyp
Keywords: nouvelles drogues; phénéthylamines substituées; cathinones substituées; méthoxétamine; cannabinoïdes de synthèse; 4-FA; 4-fluoroamphétamine; 4-MA; 4-méthylamphétamine; CB1; récepteurs cannabinoïdes de type 1; CS; cannabinoïdes de synthèse;
Keywords: Endocannabinoids; CB1; obesity; energy balance; food intake; metabolism
Keywords: CB1R; cannabinoid type 1 receptor; TRPV1; transient receptor potential vanilloid receptor 1; SS; seizure severity; SD; seizure duration; ADD; afterdischarge duration; ADT; afterdischarge threshold; Cum ADD; cumulative afterdischarge duration; DCX; doublec
Keywords: AC; acid ceramidase; ACTH; adrenocorticotropic hormone; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; ASM; acid sphingomyelinase; BDNF; brain-derived nerve growth factor; CB1; cannabinoid 1 receptor; CDP-DAG; cytidine diphosphate diacylg
Keywords: 2-AG; 2-arachidonylglycerol; 2-OG; 2-oxogluteric acid; AEA; N-arachidonoylethanolamide; CB1; cannabinoid type 1 receptor; CB1â/â/CB2â/â; CB1 and CB2 deficient; CB2; cannabinoid type 2 receptor; CK; cytokeratin; DAGLα; diacylglycerol lipase α; DA
Keywords: BBB; blood brain barrier; ARC; arcuate nucleus of hypothalamus; NPY; neuropeptide Y; AgRP; agouti-related peptide; POMC; pro-opiomelanocortin; αMSH; α-melanocyte stimulating hormone; LepRb; leptin receptor; JAK2; janus kinase 2; STAT3; signal transducer
Keywords: ANOVA; analysis of variance; CB1; cannabinoid receptor 1; D2; dopamine receptor 2; L-DOPA; l-3,4-dihydroxyphenylalanine; OD; orofacial dyskinesia; MAO; monoaminoxidase; PBS; phosphate buffered saline; SR141716A; 5-(4-chlorophenyl)-1-(2,4-dichloro-phenyl)-
Keywords: Abn-CBD; abnormal cannabidiol,4-[(1R,6R)-3-methyl-6(1-methyletheÂnyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; ACEA; N-(2-Chloroethyl)-5Z,8Z,11Z,14Z-eicÂosatetraenamide; AM251; N-(Piperidin-1-yl)-5-(4-iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-p
Keywords: Cathinone; JWH; CB1; CB2; DAT; SERT; NET; Releaser; 5HT; TAAR1
Keywords: AAV; adeno-associated virus; aRNB; asymmetric reversible neurotransmission blocking; CB1; cannabinoid receptors type 1; CPP; conditioned place preference; DA; dopamine; DOX; doxycycline; DREADD; designer receptors exclusively activated by designer drugs;
Keywords: Amphetamine; Endocannabinoids; Glutamate; Monoamines; Endogenous opioids; Pharmacology; 5-HT; serotonin; ACh; acetylcholine; ADHD; attention-deficit/hyperactivity disorder; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; BDNF; brain-derived n
Keywords: TRPV; transient receptor potential vanilloid; TRPM; transient receptor potential melastatin; CB1; cannabinoid receptor 1; CAP; capsaicin; CPZ; capsazepine; La3+; lanthanum chloride; BCTC; N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl) tetrahydropyrazi
Keywords: ADF; acid detergent fibre; ADICP; acid detergent insoluble crude protein; ADIN; acid detergent insoluble nitrogen; ADL; acid detergent lignin; AECP; truly absorbable endogenous protein; AMCP; truly absorbable microbial protein synthesized in the rumen; AR
Keywords: 2-AG; 2-arachidonylglycerol; 5-HT; 5-hydroxytryptamine; ACC; anterior cingulate cortex; AEA; anandamide; AMPA; alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; CB1; cannabinoid receptor 1; CB2; cannabinoid type 2; CCK; cholecystokinin; CCK2; chol
Keywords: 2-AG; 2-arachidonoylglycerol; AA; arachidonic acid; ABA; activity-based anorexia; ACC1; acetyl coenzyme-A carboxylase-1; AEA; N-arachidonoylethanolamine; AN; anorexia nervosa; ARC; arcuate nucleus; BBB; blood-brain barrier; BED; binge eating disorder; BN;
Keywords: ACAT; acyl-CoA cholesterol acyltransferase; ACC; acetyl CoA carboxylases; ACLY; ATP citrate lyases; ACSL; acyl CoA synthetases long chain family; ADRP; adipose differentiation related protein; AGP; advanced glycation end products; AGPAT; acylglycerophosph
Keywords: AMT; α-methyl-l-tryptophan; BBB; blood-brain barrier; CB1; cannabinoid receptor type 1; CB2; cannabinoid receptor type 2; CNS; central nervous system; FLAIR; fluid-attenuated inversion recovery; Gd-DTPA; gadolinium-diethylenetriaminepentacetate; GFAP;